135 related articles for article (PubMed ID: 9020912)
1. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.
Ma LW; Berg K; Danielsen HE; Kaalhus O; Iani V; Moan J
Cancer Lett; 1996 Dec; 109(1-2):129-39. PubMed ID: 9020912
[TBL] [Abstract][Full Text] [Related]
2. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
3. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin.
Benstead K; Moore JV
Br J Cancer; 1990 Jul; 62(1):48-53. PubMed ID: 2390482
[TBL] [Abstract][Full Text] [Related]
5. The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice.
Grau C; Høyer M; Overgaard J
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1141-6. PubMed ID: 7961023
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
7. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
Peng Q; Moan J
Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
Evensen JF; Sommer S; Rimington C; Moan J
Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
[TBL] [Abstract][Full Text] [Related]
10. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
van Geel IP; Oppelaar H; Oussoren YG; Schuitmaker JJ; Stewart FA
Br J Cancer; 1995 Aug; 72(2):344-50. PubMed ID: 7640216
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours.
Chan WS; Brasseur N; La Madeleine C; Ouellet R; van Lier JE
Eur J Cancer; 1997 Oct; 33(11):1855-9. PubMed ID: 9470846
[TBL] [Abstract][Full Text] [Related]
13. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O
Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
[TBL] [Abstract][Full Text] [Related]
14. Fractionated treatment of CaD2 tumors in mice sensitized with aluminium phthlocyanine tetrasulfonate.
Anholt H; Moan J
Cancer Lett; 1992 Jan; 61(3):263-7. PubMed ID: 1739951
[TBL] [Abstract][Full Text] [Related]
15. On the combination of photodynamic therapy with ionizing radiation.
Luksiene Z; Kalvelyte A; Supino R
J Photochem Photobiol B; 1999; 52(1-3):35-42. PubMed ID: 10643073
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
17. Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo.
Hajri A; Coffy S; Vallat F; Evrard S; Marescaux J; Aprahamian M
Br J Surg; 1999 Jul; 86(7):899-906. PubMed ID: 10417562
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with chlorin e(6) for skin metastases of melanoma.
Sheleg SV; Zhavrid EA; Khodina TV; Kochubeev GA; Istomin YP; Chalov VN; Zhuravkin IN
Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):21-6. PubMed ID: 14738529
[TBL] [Abstract][Full Text] [Related]
20. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
